Exponent, Inc.

As of September 10, 2025, Exponent, Inc. has shifted to a bearish trend, indicated by negative signals from moving averages and MACD, and has underperformed the S&P 500 with year-to-date and one-year returns of -21.26% and -35.33%, respectively.

As of August 1, 2025, Exponent, Inc. is considered very expensive with a P/E ratio of 54 and has underperformed the S&P 500, indicating significant overvaluation.

As of May 20, 2025, Exponent, Inc. is considered overvalued with a high P/E ratio of 54, an EV to EBITDA ratio of 33.13, and a PEG ratio of 17.23, despite strong ROCE and ROE metrics, while its stock has underperformed the S&P 500 by 17.23% year-to-date.

As of June 10, 2025, Exponent, Inc. is in a bearish trend with moderate strength, indicated by bearish moving averages, a bearish monthly MACD, and underperformance relative to the S&P 500.

As of March 2022, the management team of Exponent, Inc. includes Dr. Paul Johnston (Chairman), Dr. Catherine Corrigan (CEO), Dr. John Shoven (Lead Independent Director), and several independent directors: Mr. George Brown, Ms. Carol Lindstrom, Ms. Karen Richardson, and Ms. Debra Zumwalt. They oversee the company's strategic direction and operations.

Exponent, Inc. is a small-cap science and engineering consulting firm in the construction industry, with recent net sales of $146 million and a net profit of $27 million. Key metrics include a P/E ratio of 54.00 and a dividend yield of 1.23%.

As of Jun 18, Exponent, Inc. has a market capitalization of $4.8 billion, with net sales of $559.1 million and a net profit of $105.5 million over the last four quarters.